Comparison 13. SE ‐ Subjects with at least one TEAEs.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Citalopram versus TCAs	7	1088	Odds Ratio (M‐H, Random, 95% CI)	0.65 [0.30, 1.41]
1.1 versus Amitriptyline	4	528	Odds Ratio (M‐H, Random, 95% CI)	0.43 [0.28, 0.65]
1.2 versus Imipramine	2	517	Odds Ratio (M‐H, Random, 95% CI)	1.82 [1.14, 2.89]
1.3 versus Nortriptyline	1	43	Odds Ratio (M‐H, Random, 95% CI)	0.94 [0.20, 4.39]
2 Citalopram versus heterocyclics	1	336	Odds Ratio (M‐H, Random, 95% CI)	0.84 [0.52, 1.37]
2.1 versus Mianserin	1	336	Odds Ratio (M‐H, Random, 95% CI)	0.84 [0.52, 1.37]
3 Citalopram versus other SSRIs	15		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
3.1 Versus Escitalopram	7	1979	Odds Ratio (M‐H, Random, 95% CI)	1.20 [0.97, 1.47]
3.2 Versus Fluoxetine	3	732	Odds Ratio (M‐H, Random, 95% CI)	1.10 [0.81, 1.47]
3.3 Versus Paroxetine	1	406	Odds Ratio (M‐H, Random, 95% CI)	1.34 [0.83, 2.18]
3.4 Versus Sertraline	5	902	Odds Ratio (M‐H, Random, 95% CI)	0.67 [0.39, 1.16]
4 Citalopram versus SNRIs	1		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
4.1 Versus Venlafaxine XR	1	151	Odds Ratio (M‐H, Random, 95% CI)	0.46 [0.24, 0.88]
5 Citalopram versus MAOIs or newer ADs	1		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
5.1 versus Moclobemide	1	42	Odds Ratio (M‐H, Random, 95% CI)	0.69 [0.20, 2.35]
6 Citalopram versus other conventional ADs	2		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
6.1 versus Mirtazapine	1	270	Odds Ratio (M‐H, Random, 95% CI)	1.22 [0.73, 2.04]
6.2 versus Reboxetine	1	357	Odds Ratio (M‐H, Random, 95% CI)	0.64 [0.42, 0.97]
7 Citalopram versus non‐conventional ADs	1		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
7.1 versus Hypericum (St. John's wort)	1	258	Odds Ratio (M‐H, Random, 95% CI)	1.69 [1.01, 2.83]